Non-classical Notch signaling by MDA-MB-231 breast cancer cell-derived small extracellular vesicles promotes

Hernán González-King1, Sandra Tejedor1, María Ciria1

  • 1Regenerative Medicine and Heart Transplantation Unit, Instituto de Investigación Sanitaria la Fe, Valencia, Spain.

Cancer Gene Therapy
|January 13, 2022
PubMed

Insights

Small extracellular vesicles (SEVs) transfer functional Notch signaling components, including Notch1 intracellular domain (N1ICD), between breast cancer cells. This SEV-mediated pathway promotes cancer progression and invasiveness, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Aberrant Notch signaling is linked to poor breast cancer outcomes.
  • Small extracellular vesicles (SEVs) are increasingly recognized as regulators of cellular communication.
  • Notch pathway components, Notch1 and its intracellular domain (N1ICD), are implicated in cancer progression.

Purpose of the Study:

  • To investigate the role of SEVs in functional Notch signaling in breast cancer.
  • To determine if Notch components are packaged into SEVs and if they are functional.
  • To assess the impact of SEV-mediated Notch signaling on breast cancer aggressiveness.

Main Methods:

  • Utilized breast cancer cell models (MDA-MB-231 and MCF-7).
  • Analyzed Notch component packaging into SEVs.
  • Assessed the functional impact of SEV-derived Notch components on recipient cells.
  • Investigated the effect of N1ICD neutralization in SEVs.

Main Results:

  • Notch components, including N1ICD, were detected in SEVs derived from breast cancer cells.
  • SEVs from aggressive MDA-MB-231 cells transferred functional Notch signaling to less invasive MCF-7 cells.
  • SEV-mediated Notch signaling promoted target gene expression, increased invasiveness, proliferation, and mesenchymal features.
  • Neutralizing N1ICD in SEVs reduced their ability to enhance cancer cell aggressiveness.

Conclusions:

  • SEVs mediate a non-classical pathway for Notch signal transduction in breast cancer.
  • This SEV-driven pathway bypasses traditional ligand-receptor interactions.
  • SEV-mediated Notch signaling contributes to breast cancer progression and invasiveness.
  • Targeting SEV-mediated Notch signaling may offer novel therapeutic strategies for breast cancer.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.2K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K